skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: What is the consensus for revenue and adjusted ebitda?

thanks
Read Answer Asked by sandy on February 10, 2016
Q: HI Peter and team - I hold some Concordia in a US account and am interested in adding Concordia to my Canadian account. However it has a P/E ratio of about 190. Of how much concern should this be. What would it take to bring this P/E down to a more reasonable level and is Concordia on track for this. Thanks.

Rob
Read Answer Asked by Rob on February 09, 2016
Q: I am looking to deploy cash in my TFSA (2016 contribution) and with so many beaten up stocks I am wondering what to buy. I was considering the healthcare section and adding to my existing position in GUD, or perhaps initiate a position in CRH. GUD is now below its financing of $6.75 done around Dec 2014. What are your comments on GUD? Add now or wait for a better market? Or do you prefer CRH or something else in the healthcare sector. Longer term hold, and for a TFSA.

In healthcare I own CXR and GUD, smaller positions in DR and PHM, and very small positions in SIS and PM.
Read Answer Asked by Paul on February 09, 2016
Q: I am up 25% in 1030, a long term holding but down on both of the 1033 and 1042. Would appreciate your advise as to sell or move into other Mfund. Many thanks, J.A.P, Burlington
Read Answer Asked by Joseph on February 09, 2016
Q: HI there team. May I get your opinion of RNN Rexahn Pharmaceuticals in NYSE. Thanks!
Read Answer Asked by Robby on February 08, 2016
Q: My bank adviser recommended this fund. It has gone from $30 to $50 in the last 2 years. I see a MER of 3.10 and it has back end load.
Can you tell me how this back end load works in general and what you think of this fund? I wonder if there is a little bit of conflict of interest here because the bank sponsors this fund.
Read Answer Asked by Robert on February 05, 2016
Q: I would appreciate your opinion on Rockwell Medical (RMTI.US).
Is it buy at this level?
Thank you.

Milan
Read Answer Asked by Milan on February 04, 2016
Q: Would appreciate your opinion on MSL after acquisition news.
Some research puts fair value at $3.50 pre acquisition.
Thank you.
Read Answer Asked by howard on February 03, 2016
Q: Gild has had a drop -- Pfe is more defensive (Div) . I am down sl. on PFE --thinking of switching. Concerned re the next drop ( MKT drop not over ) ---would you selll Pfe now & buy Gild at lower price. Or sell Pfe now & take a partial position --after Weds
--Div. day for pfe, Thank you-- great site . great insight
don
Read Answer Asked by Dr. Donald on February 02, 2016
Q: Could I please have your take on the latest news from this company and the new products they have acquired today?
Thank You
Garry
Read Answer Asked by garry on February 02, 2016
Q: "Yesterday there were two 500,000+ blocks at $6.60. We think the moves in the sector are entirely political worries, or sector rotation (into energy perhaps) but can't offer much more here. "


In your response to David's question I interpret it that someone(s) sold 2 blocks of 500K shares at $6.60.

I suggest it was someone(s) buying at a low. Especially considering it is rising now. I do not know if they were Black Pool buys.

Could these be viable possibilities?
Read Answer Asked by Stan (1) on January 29, 2016
Q: Hi again,

I have some IBB biotech etf which has followed the sector down. Do you see any positive potential for this sector over the next quarter or so?

Thanks
Read Answer Asked by Gary on January 29, 2016
Q: Hello.
Thanks for quality answers to questions.

Would you please help by offering insight to dealing with investor psychology and behaviour; 50% gain in PHM only to now be in the red on this holding?
My current thinking does not make sense to me to hold at the top of a gain only to feel like getting out now that the stock price has declined to the point that it feels like a poor investment decision.
I have been drawn into more aggressive type investments being connected to this subscription (beyond normal style) so I believe I can benefit from your experience and comments about dealing with volatility of the nature in this question.
Thanks
Dave

Read Answer Asked by David on January 29, 2016
Q: Re your answer is insider buying not worthy of a comment?
Read Answer Asked by j stuart on January 29, 2016
Q: i have been noticing a fairly large uptick in volume on knight over the last few days or weeks,normally it trades around 100k a day, but lately much more, maybe your bloomberg terminal give you more info than i can see.
also healthcare stocks across the board are selling off, concordia, knight, phm and even large biotechs in u.s. is this all because of hilary and u.s. election or something else. dave
Read Answer Asked by david on January 29, 2016
Q: Thoughts on CXR looking very attractively priced at the moment? They've got enough international exposure to their business that any action in the US to lower drug prices (which would likely take a new government and years to pass legislation) would not have a significant impact on CXR's business. Clinton's new video against Valeant and people panicking and selling CXR seem to be providing a great entry point.
Read Answer Asked by Arneh on January 29, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!